outcome of related and unrelated cord-blood transplantation in children at hematopoietic stem cell transplantation research center of shariati hospital
نویسندگان
چکیده
introduction: in 1989, the first successful umbilical cord blood transplantations (ucbts) was reported in a boy with fanconi's anemia, using umbilical cord (ucb) of his hla matched sister. cord blood transplantation is a good substitute for bone marrow or peripheral blood transplantation especially for children and small body size adults. methods: between 1998 and 2007 ,14 children(10 boys and 4 girls ) with non-malignant(9 beta-thalassemia major ,3 scid,1 hurler) and malignant(1 aml) diseases were given an allogenic cb transplant from sibling (10 cases) or unrelated(4 cases). in the majority of cases, busulfan and cyclophosphamide were given in various dosage in conditioning regimen gvhd prophylaxis consisted mainly of (csa) alone( in 9 cases), the combination of csa and methoterxate (in 4 cases)and methotrexate alone (in 1 case). results: in thalassemic patients 89% are alive but 55% with disease. graft failure occurred in 4 thalassemic and 1 aml patients. only 2 cases experienced gvhd (1 acute gvhd grade2 and 1limited chronic gvhd). all three cases of scid that transplanted very late after many infectious complications are dead. conclusion: this study demonstrated that cbt is curative in some thalassemic patients but in future, we can improve results of cbt with use of atg, alemtuzumab, thiotepa, g-csf, double cord, tnc dose of 4×107/kg and elimination of methotrexate for gvhd prophylaxis in hla- match sibling.
منابع مشابه
Pediatric Hematopoietic Stem Cell Transplantation
The introduction and evolution of hematopoietic stem cell transplantation (HSCT) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. Today, HSCT is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...
متن کاملAdvances in Hematopoietic Stem Cell Mobilization and Peripheral Blood Stem Cell Transplantation
Hematopoietic stem/progenitor cells (HSPCs) which give rise to different blood cell types are present within the bone marrow microenvironment, especially in flat bones such as skull, vertebrae, pelvis and chest. Interacting factors such as stromal derived factor-1/CXCR4, very late antigen-4/vascular cell adhesion molecule-1, Lymphocyte function-associated antigen-1/ intercellular adhesion molec...
متن کاملUnrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?
Hematopoietic cell transplantation (HCT) can be curative for selected malignant and nonmalignant diseases.1-13 However, utilization and success of HCT are limited by several obstacles, primarily related to the importance of donor-recipient genetic match for favorable outcomes. While in most settings, best results are offered by human leukocyte antigen (HLA)14,15–identical sibling transplantatio...
متن کاملHematopoietic Stem Cell Transplantation for Thalassemia
Thalassemia is an autosomal recessive disorder associated with defective synthesis of the α- or β-chain of hemoglobin. For β-thalassemia major patients, therapeutic options are either monthly red cell transfusions and chelation therapy or allogeneic stem cell transplant. Stem cell transplant is the only curative approach and success is inversely correlated with the degree of iron overload and h...
متن کاملUnrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.
UCBT was performed in seven children with SCD and stroke (HLA match 4/6 n=5; 5/6 n=2). Four received myeloablative regimens (BU, CY, ATG plus FLU in one patient). One had primary graft failure, three had sustained engraftment, two with grade III-IV GVHD (one died, one developed chronic GVHD), one with stable mixed chimerism. Three patients treated with reduced-intensity regimens (FLU, BU or CY,...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of hematology-oncology and stem cell researchجلد ۳، شماره ۱، صفحات ۱۷-۲۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023